News

February 23, 2017

Gastroenterologists across the nation are looking for options to treat their patients with irritable bowel syndrome (IBS), especially those who represent the largest group of IBS sufferers with IBS-M (mixed diarrhea and constipation).

Read More

December 19, 2016

IM HealthScience® (IMH) today announced favorable results from its Irritable Bowel Syndrome Safety Update at 12 Months (IBSSU-12), a real-world surveillance study reporting on the safety and tolerability profile of IBgard®.

Read More

December 14, 2016

For the second consecutive year, IBgard® continues to be the #1 recommended peppermint oil for IBS among gastroenterologists by an overwhelming margin.

Read More

IBgard brings symptom relief to millions of Canadians

October 26, 2016

Today IM HealthScience®, announced the availability of IBgard®, a new natural health product for IBS – a condition that affects more than five million Canadians.

Read More

Final results of real-world data confirm high levels of patient satisfaction

October 17, 2016

IM HealthScience® (IMH) today announced the complete and final results of IBSACT™ (Irritable Bowel Syndrome Adherence and Compliance Trial), a real-world observational study of 630 patients who took IBgard®.

Read More

Continuing developments in consensus on utility of peppermint oil for IBS

September 27, 2016

IM HealthScience® (IMH) today announced that the growing medical consensus on the utility of peppermint oil in Irritable Bowel Syndrome (IBS) has been highlighted once again

Read More

Real-world data confirms excellent safety and tolerability profile of IBgard

August 29, 2016

IM HealthScience® (IMH) today announced favorable results from its Irritable Bowel Syndrome Safety Update at 6 Months (IBSSU- 6), a real-world surveillance study…

Read More

High patient satisfaction and demand results in expansion of IBgard availability

August 9, 2016

IM HealthScience® (IMH) today announced that in response to growing feedback from doctors to make IBgard® more available for their patients, it is expanding retail access of IBgard®.

Read More

Recent opinion editorial reflects important role of non-prescription options

August 2, 2016

Recent opinion editorial in Newsweek Magazine reflects growing concern over rising costs of healthcare and prescription medications and important role of non-prescription options.

Read More

Demand for IBgard results in expansion to Rite Aid stores

June 9, 2016

IM HealthScience® (IMH) today announced that in
response to growing patient demand for broader retail access, it is increasing availability of IBgard® in Rite Aid stores nationwide. Rite Aid stores will stock IBgard® in 12-capsule and 48-capsule boxes.

Read More

Access to this section is intended for Healthcare Practitioners only.

Please confirm below that you are a Healthcare Practitioner or click here to return to the consumer section of the site.

Confirm